Belumosudil-Induced Reductions in Sirolimus Dosing for Pediatric Chronic GVHD (cGVHD).

Transplantation and Cellular Therapy 2026

View at publisher
Authors: Urvi Kapoor, Muna D. Qayed, Kirsten M. Williams, Michelle Long Schoettler, Azada Ibrahimova, Pooja Khandelwal, Ava Krogman, Jeremy Obordo, Alan Bidgoli
DOI: 10.1016/j.jtct.2025.12.900
Cited by: 0

Fields of Study & Subjects

Hematopoietic Stem Cell Transplantation Renal Transplantation Outcomes and Treatments Immunodeficiency and Autoimmune Disorders

Publication details

Journal / source
Transplantation and Cellular Therapy
Volume
32
Issue
2
Pages
S602–S603
Publication date
1 February 2026
Language
EN